We studied only 10 cases of non-ccRCC, so future studies should also examine the roles of CD39/CD73/A2AR in papillary, chromophobe, and collecting duct RCC in larger cohorts. This evidence concerns the gene ADORA2A and nonpapillary renal cell carcinoma.